Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Highbridge Capital Management | 57M | $55M | 0% | Mar 2026 |
|
| DeepCurrents Investment Group | 17M | $16M | 100% | Jun 2026 |
|
| D. E. Shaw & Co | 17M | $16M | 0% | Jun 2026 |
|
| LMR Partners | 16M | $15M | 0% | Jun 2026 |
|
| Calamos Advisors | 15M | $14M | 0% | Jun 2026 |
|
| Corbyn Investment Management | 11M | $10M | 0% | Jun 2026 |
|
| Oaktree Capital Management | 6.7M | $6.3M | 100% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 3.5M | $3.3M | 0% | Jun 2026 |
|
| Russell Investments | 3.2M | $3.0M | 100% | Jun 2026 |
|
| FMR | 1.5M | $1.4M | 3% | Jun 2026 |
|
| Financial Consulate | 1.0M | $991k | 5% | Jun 2026 |
|
| Advent Capital Management | 1.0M | $949k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 875k | $824k | -98% | Jun 2026 |
|
| Morgan Stanley | 810k | $744k | 100% | Mar 2026 |
|
| HB Wealth Management | 555k | $523k | 0% | Jun 2026 |
|
| Branch Banking & Trust Company | 71k | $67k | 0% | Jun 2026 |
|
| Capital Investment Advisory Services | 37k | $35k | 0% | Jun 2026 |
|
| Greenspring Advisors | 14k | $13k | 100% | Jun 2026 |
|
| Cambridge Investment Research Advisors | 13k | $12k | 0% | Jun 2026 |
|
| Brown Trout Management | 3.2k | $3.0M | 100% | Jun 2026 |
|
| Rothschild Investment | 1.0k | $943.000000 | 0% | Jun 2026 |
|
| UBS Group | 500.00 | $472.000000 | 0% | Jun 2026 |
|
| Alken Asset Management | 400.00 | $377k | 0% | Jun 2026 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DG Capital Management | Mar 2026 | 22M | $21M |
| Leucadia National Corporation | Mar 2026 | 90k | $83k |
| Sontag Advisory | Mar 2026 | 27k | $25k |